More than 65 per cent of MSME firms have been found to be manufacturing drugs that are not of standard quality (NSQ), during risk-based inspections of pharma companies conducted since December last year, said a person with knowledge of the matter.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment